Last reviewed · How we verify

NCT07013162

Efficacy of Laser Therapy for Periodontitis

Not yet recruiting NA Last updated 10 June 2025
What this trial tests

NA trial testing High power diode laser + SRT in Periodontal Disease in 21 participants. Not yet recruiting.

Timeline
1 July 2025
Primary endpoint
1 June 2026
1 August 2026

Quick facts

Lead sponsorUniversity of Science and Technology, Yemen
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment21
Start date1 July 2025
Primary completion1 June 2026
Estimated completion1 August 2026

Drugs / interventions tested

Conditions studied

Sponsor

University of Science and Technology, Yemen

Who can join

Adults 25 to 58, any sex, with Periodontal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the efficacy of diode laser in addition to periodontal treatment in periodontitis patients and to investigate their effects on gingival crevicular fluid (GCF) cytokine levels before and after treatment, among some Yemeni individuals in Sana'a city.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical efficacy of high versus low intensity diode laser as an adjunct to non-surgical periodontal therapy in periodontitis: randomized controlled clinical trial.
    Al-Sharani AA, Al-Hajj WA, Madfa AA. · · 2026 · PMID 41723233 · DOI 10.1038/s41598-026-40879-8

Verify or expand the search:

Other recruiting trials for Periodontal Disease

Currently open trials in the same condition.

Other University of Science and Technology, Yemen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07013162.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing